410 Medical, a medical device company developing technologies for emergency and critical care, has raised $12 million in financing led by Orlando Health Ventures. Hatteras Venture Partners, Ballad Health, OSF Healthcare, Rex Health Ventures, CU Healthcare Innovations Fund, Sarnova, Catalyst by Wellstar, Tampa General and an undisclosed strategic investor also participated. The funding will support commercial expansion and development of the next-generation LifeFlow infuser.
Expanding LifeFlow Adoption
LifeFlow products help clinicians rapidly deliver fluids and blood to patients facing sepsis, hemorrhagic shock and other life-threatening conditions. More than 500 hospitals and EMS agencies currently use the technology, with nearly 80,000 patients treated to date. The new capital will expand adoption across additional healthcare systems and emergency services.
“The heightened interest in this round reflects the confidence investors and customers have in 410 Medical’s mission and products,” said Kyle Chenet, Chief Executive Officer at 410 Medical. “With this funding, we’re able to expand our commercial reach, bringing LifeFlow to more clinicians and investing in the next generation of our technology. We’re grateful to Orlando Health Ventures for leading this round and excited to welcome Tampa General and an additional strategic partner to our syndicate.”
“Orlando Health Ventures is proud to lead this round and deepen our partnership with 410 Medical,” said Bobby Helmedag, Managing Director of Orlando Health Ventures. “LifeFlow addresses a critical gap in resuscitative care, and we’ve seen firsthand the impact it can have for clinicians and patients. We’re excited to support the team as they scale commercial operations and advance the next generation of the LifeFlow infuser.”
Next-Generation Infusion Technology
410 Medical plans to launch the next generation of LifeFlow in 2027. Built on nearly a decade of feedback from frontline medical providers, the new device will focus on greater speed, portability and ease of use in critical resuscitation settings.